Literature DB >> 8610085

Psychological response to cervical screening.

S Bell1, M Porter, H Kitchener, C Fraser, P Fisher, E Mann.   

Abstract

BACKGROUND: Few studies have examined the psychological costs of cervical screening, despite expressed concern over possible negative sequelae.
METHODS: Seventy-five women with mild or moderately dyskaryotic smears, under cytological surveillance, 75 women referred for colposcopy after a first-ever abnormal smear showing severe dyskaryosis, and 75 controls with recent negative cytology were interviewed at home, and their psychological adjustment was assessed.
RESULTS: Levels of distress were higher among women with an abnormal smear than among controls with a recent negative smear. Anxiety (Hospital Anxiety and Depression Scale range 0-21, "normal" range 0-7) was highest among those referred for colposcopy (mean 8.12, controls 5.88, P < 0.001); afterward, distress fell (mean 6.61, P < 0.001) but more problems of social adjustment were evident (surveillance vs controls, P < 0.01). High anxiety was associated with social maladjustment (colposcopy, P < 0.001; surveillance, P < 0.01) and negative feelings about the self (P < 0.05). Current anxiety was unrelated to knowledge about abnormal smears, but in the surveillance group was related to satisfaction with the explanation provided (P < 0.05).
CONCLUSION: A positive cervical smear may by psychologically traumatic for a significant minority of women, irrespective of management strategy.

Entities:  

Mesh:

Year:  1995        PMID: 8610085     DOI: 10.1006/pmed.1995.1096

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  21 in total

Review 1.  Screening for cervical cancer: a review of women's attitudes, knowledge, and behaviour.

Authors:  F Fylan
Journal:  Br J Gen Pract       Date:  1998-08       Impact factor: 5.386

Review 2.  Interventions to improve follow-up of abnormal findings in cancer screening.

Authors:  Roshan Bastani; K Robin Yabroff; Ronald E Myers; Beth Glenn
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

3.  Use of electronic health record data to evaluate overuse of cervical cancer screening.

Authors:  Jason S Mathias; Dana Gossett; David W Baker
Journal:  J Am Med Inform Assoc       Date:  2012-01-19       Impact factor: 4.497

4.  "What does this mean?" How Web-based consumer health information fails to support information seeking in the pursuit of informed consent for screening test decisions.

Authors:  Jacquelyn Burkell; D Grant Campbell
Journal:  J Med Libr Assoc       Date:  2005-07

Review 5.  Discussing the diagnosis of HPV-OSCC: common questions and answers.

Authors:  Carole Fakhry; Gypsyamber D'Souza
Journal:  Oral Oncol       Date:  2013-07-19       Impact factor: 5.337

Review 6.  There is no longer a place for underage cytology in genitourinary medicine clinics.

Authors:  C O'Mahony
Journal:  Genitourin Med       Date:  1996-12

7.  Cost-effectiveness of active versus conservative colposcopic management of mild dyskaryosis.

Authors:  Mohsen M El-Sayed; Wael I Al-Daraji; Chris M Finnegan; Wendy E Dugmore; Barbel U Vonau; Paul G Carter; Michael H Jones
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

8.  The frequency of Pap smear screening in the United States.

Authors:  Brenda E Sirovich; H Gilbert Welch
Journal:  J Gen Intern Med       Date:  2004-03       Impact factor: 5.128

9.  Developing a questionnaire to measure the psychosocial impact of an abnormal cervical smear result and its subsequent management: the TOMBOLA (Trial of Management of Borderline and Other Low-grade Abnormal Smears) trial.

Authors:  N M Gray; L Sharp; S C Cotton; M Avis; Z Philips; I Russell; L G Walker; D Whynes; J Little
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

10.  Feasibility and efficacy of a weight gain prevention intervention for breast cancer patients receiving neoadjuvant chemotherapy: a randomized controlled pilot study.

Authors:  Karen M Basen-Engquist; Margaret Raber; Cindy L Carmack; Banu Arun; Abenaa M Brewster; Michelle Fingeret; Susan M Schembre; Carol Harrison; Heidi Y Perkins; Yisheng Li; Jaejoon Song; Minxing Chen; James L Murray
Journal:  Support Care Cancer       Date:  2020-04-05       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.